Insider Transactions in Q1 2025 at A Ikido Pharma Inc. (AIKI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Anthony Hayes CEO |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+25.32%
|
-
|
|
Feb 18
2025
|
Ronald J. Lieberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+45.23%
|
-
|
|
Feb 12
2025
|
Kyle Michael Wool President |
BUY
Open market or private purchase
|
Direct |
288,184
+11.58%
|
-
|
|
Feb 10
2025
|
Robert Frederick Dudley Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+30.85%
|
-
|
|
Feb 10
2025
|
Ronald J. Lieberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+24.03%
|
-
|
|
Feb 10
2025
|
Ronald J. Lieberman Director |
BUY
Open market or private purchase
|
Direct |
21,613
+50.0%
|
-
|
|
Feb 10
2025
|
Tim S Ledwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+24.11%
|
-
|
|
Feb 10
2025
|
Tim S Ledwick Director |
BUY
Open market or private purchase
|
Direct |
8,645
+28.71%
|
-
|
|
Feb 10
2025
|
Kyle Haug Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+29.06%
|
-
|
|
Feb 10
2025
|
Kyle Haug Director |
BUY
Open market or private purchase
|
Direct |
14,409
+50.0%
|
-
|
|
Feb 10
2025
|
Christopher Franklin Devall COO |
BUY
Grant, award, or other acquisition
|
Direct |
351,851
+46.14%
|
-
|
|
Feb 10
2025
|
Christopher Franklin Devall COO |
BUY
Open market or private purchase
|
Direct |
28,818
+32.87%
|
-
|
|
Feb 10
2025
|
Gregory James Blattner Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+21.36%
|
-
|
|
Feb 10
2025
|
Gregory James Blattner Director |
BUY
Open market or private purchase
|
Direct |
14,409
+34.95%
|
-
|
|
Feb 10
2025
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
288,184
+22.81%
|
-
|